Rifampicin attenuates experimental autoimmune encephalomyelitis by inhibiting pathogenic Th17 cells responses-Reference-Cited by-同舟云学术

Rifampicin attenuates experimental autoimmune encephalomyelitis by inhibiting pathogenic Th17 cells responses

Published:2016-11-29 Issue:6 Volume:139 Page:1151-1162
ISSN:0022-3042
Container-title:Journal of Neurochemistry
language:en
Short-container-title:J. Neurochem.

Author:

Ma Ke¹^ORCID,Chen Xi¹,Chen Jia‐Cheng¹,Wang Ying¹,Zhang Xi‐meng¹,Huang Fan¹,Zheng Jun‐Jiong¹,Chen Xiong¹,Yu Wei¹,Cheng Ke‐Ling¹,Feng Yan‐Qing¹,Gu Huai‐yu²

Affiliation:

1. Department of Neurology Guangdong Key Laboratory for Diagnosis and Treatment of Major Neurological Diseases National Key Clinical Department The First Affiliated Hospital Sun Yat‐Sen University Guangzhou China

2. Department of Anatomy and Neurobiology Zhongshan School of Medicine Sun Yat‐Sen University Guangzhou China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jnc.13871

Reference46 articles.

1. Focal disturbances in the blood–brain barrier are associated with formation of neuroinflammatory lesions

2. Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12